Product Images Gialax

View Photos of Packaging, Labels & Appearance

Product Label Images

The following 5 images provide visual information about the product associated with Gialax NDC 70569-840 by Phlight Pharma, Llc, such as packaging, labeling, and the appearance of the drug itself. This resource could be helpful for medical professionals, pharmacists, and patients seeking to verify medication information and ensure they have the correct product.

GIALAX layout - GIALAX layout

GIALAX layout - GIALAX layout

PEG insert p1 - PEG insert p1

PEG insert p1 - PEG insert p1

Polyethylene Glycol 3350, NF Powder for Oral Solution is a synthetic polyglycol used as an osmotic agent for the treatment of occasional constipation. It works by causing water to be retained in the stool, increasing bowel movement frequency and daily stool weight. This product is contraindicated in patients with known or suspected bowel obstruction and patients allergic to polyethylene glycol. It should be used for 2 weeks or less or as directed by a physician. Clinical trials have shown its efficacy in improving bowel movement frequency compared to placebo.*

PEG insert p2 - PEG insert p2

PEG insert p2 - PEG insert p2

Polyethylene Glycol 3350, NF is a medication that softens stool and alleviates constipation by retaining water in stool. It is usually taken orally after being dissolved in water, juice, soda, coffee, or tea. The product should be used for two weeks or less as prolonged use may result in an electrolyte imbalance and a reliance on laxatives. Before using Polyethylene Glycol 3350, NF, patients should undergo a thorough medical examination to rule out relevant medical conditions. The medication is not known to have any clinically significant effects on laboratory tests or specific drug interactions but, like all medications, should be used with caution if needed during pregnancy or in pediatric patients. The use of Polyethylene Glycol 3350, NF in elderly patients should be closely monitored, especially in nursing home patients, as there was a greater incidence of diarrhea in a particular study.*

PEG insert p3 - PEG insert p3

PEG insert p3 - PEG insert p3

This text provides information on the adverse reactions, dosage, administration, overdosage, and packaging of Polyethylene Glycol 3350, NF Powder for Oral Solution. Adverse reactions may include nausea, abdominal bloating, cramping, flatulence, and diarrhea at high doses. The usual dose is 17 grams per day dissolved in water, juice, soda, coffee, or tea, with a dosing cap marked to contain 17 grams of the laxative powder when filled to the indicated line, and may take two to four days to produce a bowel movement. Overdosage may cause diarrhea, dehydration, and excessive stool frequency, making it necessary to terminate medication and administer free water. The product is supplied in two package sizes, stored at 20° - 25°C (68° - 77°F), and distributed by Kremers Urban Pharmaceuticals Inc.*

PEG insert p5 - PEG insert p4

PEG insert p5 - PEG insert p4

Polyethylene Glycol 3350, NF Powder for Oral Solution is a laxative suitable only for people suffering from constipation, with a dose of 17 grams each day or as directed by a physician. It softens the stool and increases the frequency of bowel movements by retaining water in it. The product achieves its best results when used between one and two weeks. Polyethylene Glycol 3350, NF should not be used by children and pregnant women unless prescribed by the physician. Side effects include nausea, stomach fullness, cramping, diarrhea, gas, and rare allergies. Ensure to keep it and other drugs out of reach of children, and store it at 20-25°C (68°-77°F); excursions are permitted between 15°-30°C (59°-86°F). Distributed by Kremers Urban Pharmaceuticals Inc., Princeton, NJ 08540, USA.*

* The product label images have been analyzed using a combination of traditional computing and machine learning techniques. It should be noted that the descriptions provided may not be entirely accurate as they are experimental in nature. Use the information in this page at your own discretion and risk.